{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "North Wales",
      "address_1": "1090 Horsham Rd",
      "reason_for_recall": "Labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles.",
      "address_2": "",
      "product_quantity": "576 bottles",
      "code_info": "Lot #: 05N533, Exp 11/16",
      "center_classification_date": "20160311",
      "distribution_pattern": "Nationwide and Puerto Rico.",
      "state": "PA",
      "product_description": "NABUMETONE Tablets USP, 750 mg, 100 count bottle,Teva Pharmaceutical Industries Ltd., Jerusalem, 91010, ISRAEL",
      "report_date": "20160323",
      "classification": "Class III",
      "openfda": {},
      "recalling_firm": "Teva Pharmaceuticals USA",
      "recall_number": "D-0773-2016",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "72999",
      "termination_date": "20161115",
      "more_code_info": "",
      "recall_initiation_date": "20151119",
      "postal_code": "19454-1505",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}